Research overview
Cosmetic Peptides in Research: GHK, AHK-Cu, SNAP-8, Matrixyl and PTD-DBM
14 November 2026 · 6 min read
Why skin peptides end up in laboratories
Skin peptides are short chains of amino acids that have been the subject of frequent in vitro work on skin biology for several years. For a researcher, their appeal is a small, well-described molecule that can be synthesised in pure form and compared with other compounds under the same conditions. Below we discuss five reagents that appear most often in such comparisons: GHK, AHK-Cu, SNAP-8, Matrixyl and PTD-DBM. Each belongs to a different category, so comparing them requires understanding how they differ.
All products described in this article are reagents for laboratory research (Research Use Only). They are not intended for use in humans or animals. The descriptions refer to results from cell cultures, in vitro models and animal models.
Copper carriers: GHK and AHK-Cu
The first category covers peptides that bind copper(II) ions. GHK is a tripeptide made of glycine, histidine and lysine (Gly-His-Lys). Its copper-free form, GHK, serves as a reference point for research on the GHK-Cu complex. The imidazole ring of histidine provides coordination sites for the Cu2+ ion, which is why solution pH and the peptide-to-copper ratio matter a great deal in the laboratory.
AHK-Cu is a copper(II) complex of the tripeptide alanine, histidine, lysine (Ala-His-Lys). It differs from GHK-Cu by one amino acid at the start of the sequence: alanine replaces glycine. This small change shows how a minor modification to a sequence can shift the research profile of a compound. In the work described, AHK-Cu was studied mainly in hair follicle models, using dermal papilla cell cultures.
In both cases, controlling the copper ion itself is essential. A well-designed experiment includes a group with copper alone under the same conditions, so the effect of the peptide can be separated from the effect of the metal. Without such a control, the interpretation of results remains incomplete.
Signalling peptides: Matrixyl and PTD-DBM
Matrixyl, also known as palmitoyl pentapeptide-4, is a pentapeptide with the sequence KTTKS and a palmitic acid attached to the N-terminus. The sequence derives from a fragment of type I collagen. The palmitoyl group increases the lipophilicity of the molecule, which is one reason the compound is often chosen for models of peptide penetration through membranes. In fibroblast cultures, effects on the synthesis of type I collagen and other extracellular matrix components have been described. The reagent is available as Matrixyl.
PTD-DBM is a peptide carrying a protein transduction domain (PTD). Such a domain facilitates passage of the molecule across the cell membrane in culture, allowing the peptide to act inside the cell. In the work described, it was associated with Wnt signalling, specifically with disruption of the interaction between the CXXC5 protein and Dishevelled. The mechanism has been described in experimental models and is not fully explained, so it is best treated as a hypothesis to verify rather than a settled answer.
Signalling peptides share one trait: the outcome depends on cell type, concentration and exposure time. The same molecule can give different readings in fibroblasts, keratinocytes and in a reconstructed skin model, so planning a series starts with choosing the model and only then the peptide.
Neurotransmitter-related peptide: SNAP-8
SNAP-8, known as acetyl octapeptide-3, is an eight-amino-acid peptide whose structure resembles a fragment of the SNAP-25 protein. SNAP-25 belongs to the SNARE protein family, which forms a complex linking vesicles to the cell membrane. This complex governs exocytosis, the release of vesicle contents, including neurotransmitters.
In in vitro models, SNAP-8 has been described as potentially competing with native SNAP-25 for a role in SNARE complex assembly, which alters the course of exocytosis in a cellular model. For this reason SNAP-8 is used as a tool for research on signalling and neurotransmitter release, and in comparisons of skin-category peptides under identical conditions.
The short sequence makes SNAP-8 a convenient model for analysing the relationship between peptide structure and behaviour. Placing it alongside peptides with a different mechanism helps establish which effects come from the sequence itself and which come from the experimental context.
Comparing five peptides in one project
The most common mistake when working with skin peptides is comparing results from different series prepared under different conditions. Each compound should have its own control group, and solutions should be prepared in the same buffer, at the same pH and at a similar time after reconstitution.
A good starting point is a table that collects the key features of each compound before the experiment begins:
| Peptide | Category | Main research direction |
|---|---|---|
| GHK | copper carrier, copper-free form | reference point for GHK-Cu |
| AHK-Cu | copper carrier | in vitro hair follicle models |
| Matrixyl | signalling peptide | collagen synthesis in fibroblasts |
| PTD-DBM | signalling peptide, transduction | Wnt pathway and CXXC5 protein |
| SNAP-8 | neurotransmitter-related peptide | SNARE complex assembly |
The table does not replace reading the publications, but it organises decisions. It is worth adding your own parameters: concentration, incubation time and cell type.
How to read results from skin models
Readouts in this research are usually indirect. Researchers measure mRNA levels, the amount of protein secreted into the medium, the activity of matrix-remodelling enzymes, or images of cells under a microscope. Each of these parameters says something different, so a single readout rarely supports a conclusion. Good practice is to confirm the direction of change at two levels, for example gene expression and protein.
Reproducibility matters just as much. The same conditions, the same reagent batch and the same method of solution preparation should apply to every comparative series. Recording each step, from the reconstitution date to pH and storage temperature, makes it possible to reproduce a result later or explain a discrepancy between series.
It is also worth keeping the limits of models in mind. A fibroblast culture, a reconstructed skin model and a single-cell-type system reflect only part of a complex tissue. Results from such systems describe cell behaviour under specific conditions and do not transfer automatically to other models. A well-designed study therefore compares several models and includes controls that separate the effect of the peptide from the effect of the solvent, the metal or the culture process itself.
A practical sequence helps when the first series is planned. Start with a pilot run on one model, using one peptide at two concentrations, and add the copper control and the remaining compounds only once the handling of the solutions is stable. A pilot shows whether the readout is sensitive enough and whether the vehicle or the culture medium changes the signal on its own. Only then should the full five-peptide comparison be scheduled, with every compound run in parallel and placed in a randomised plate layout, so that position effects on the plate are not mistaken for differences between peptides.
Working in the laboratory
All five reagents are supplied as lyophilisate. Each batch has a purity of at least 99%, confirmed by HPLC, and its mass is verified by MS. We dispatch orders within 24 h: to InPost parcel lockers in Poland and by DPD courier to European countries.
Store the lyophilisate at -20 °C, tightly closed, protected from light and moisture. Before opening a vial, let it reach room temperature so that water does not condense on the powder. After reconstitution, keep the solution at 2-8 °C, avoid repeated freezing and thawing, and divide it into working aliquots.
Choose the solvent according to the study protocol; bacteriostatic water is the most common choice. You can convert concentration and volume in the concentration calculator.